within Pharmacolibrary.Drugs.ATC.A;

model A01AC01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 3.111111111111111e-06,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,
    adminCount     = 1,
    Vd             = 0.0975,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Triamcinolone</td></tr><tr><td>ATC code:</td><td>A01AC01</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Triamcinolone is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties, used to treat a range of conditions such as oral inflammatory diseases (as a dental paste), dermatological disorders, and allergic reactions. It is approved and currently used in various formulations including topical, oral, inhalational, and injectable forms.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adults for oral topical (dental paste/buccal) administration; literature reporting specific parameters for the dental paste or topical oral form is lacking. Estimates are extrapolated from systemic use and closely related topical or oral administration data.</p><h4>References</h4><ol><li><p>Ramadas, AA, et al., &amp; Kumar, SP (2016). Systemic absorption of 0.1% triamcinolone acetonide as topical application in management of oral lichen planus. <i>Indian journal of dental research : official publication of Indian Society for Dental Research</i> 27(3) 230â€“235. DOI:<a href=\"https://doi.org/10.4103/0970-9290.186237\">10.4103/0970-9290.186237</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27411649/\">https://pubmed.ncbi.nlm.nih.gov/27411649</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>"
  ));
end A01AC01;
